547 studies found for:    Open Studies | "Ovarian Diseases"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Ovarian Diseases"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Mediterranean Diet Versus Hypocaloric Diet in PCOS
Condition: Polycystic Ovary Syndrome
Interventions: Other: mediterranean diet, restricted calorie;   Other: hypocaloric diet, restricted calorie
2 Recruiting Mediterranean Diet as Treatment for Normal Weight Women With PCOS
Condition: Polycystic Ovary Syndrome
Interventions: Other: mediterranean diet;   Other: normocaloric diet
3 Recruiting Low Dose Cyclophosphamide +/-- Nintedanib in Advanced Ovarian Cancer
Conditions: Ovarian Cancer;   Fallopian Tube Cancer
Intervention: Drug: BIBF 1120
4 Recruiting Urinary DENND1A.V2 as a Predictor of Pubertal Hyperandrogenemia
Conditions: Polycystic Ovary Syndrome;   Hyperandrogenism;   Puberty
Intervention: Other: Phenotype/genotype assessment
5 Not yet recruiting Medical Assistance for the Procreation and Risk of Thrombosis.
Conditions: Ovarian Hyperstimulation Syndrome;   Cardiovascular Diseases;   Embolism and Thrombosis
Intervention: Other: ovarian stimulation
6 Not yet recruiting A Study of Pembrolizumab With Standard Treatment in Patients With Recurrent Platinum-resistant Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: Pembrolizumab;   Drug: Gemcitabine;   Drug: Cisplatin
7 Recruiting Taichi for Overweight/Obese Adolescent and Young Women With Polycystic Ovary Syndrome (PCOS)
Condition: Polycystic Ovary Syndrome
Interventions: Behavioral: Taichi;   Behavioral: Self-monitored exercise
8 Not yet recruiting A Study to Explore Correlation Between Symptoms and Signs of Polycystic Ovarian Syndrome (PCOS) and Risk of Over-response to Ovarian Stimulation
Condition: Polycystic Ovary Syndrome
Interventions: Drug: Gonal-f®;   Drug: Long GnRH agonist;   Drug: GnRH antagonist
9 Not yet recruiting Study of IMGN853 in Comb. With Bevacizumab, Carboplatin or PLD in Adults With FRa + Adv. EOC, Primary Peritoneal, Fallopian Tube, or Endometrial Cancer
Conditions: Epithelial Ovarian Cancer;   Primary Peritoneal Cancer;   Fallopian Tube Cancer;   Endometrial Cancer
Interventions: Drug: IMGN853;   Drug: Bevacizumab;   Drug: Carboplatin;   Drug: Doxorubicin
10 Recruiting Autologous Adipose Derived Mesenchymal Stromal Cells Transplantation in Women With Premature Ovarian Failure (POF)
Condition: Premature Ovarian Failure
Intervention: Biological: Intraovarian injection of Adipose derived Stromal cells (ADSCs)
11 Not yet recruiting A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma
Conditions: Malignant Rhabdoid Tumors (MRT);   Rhabdoid Tumors of the Kidney (RTK);   Atypical Teratoid Rhabdoid Tumors (ATRT);   Selected Tumors With Rhabdoid Features;   Synovial Sarcoma;   INI1-negative Tumors;   Malignant Rhabdoid Tumor of Ovary
Intervention: Drug: Tazemetostat
12 Not yet recruiting A Phase 1 Study of the EZH2 Inhibitor Tazemetostat in Pediatric Subjects With Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma
Conditions: Rhabdoid Tumors;   INI1-negative Tumors;   Synovial Sarcoma;   Malignant Rhabdoid Tumor of Ovary
Intervention: Drug: Tazemetostat
13 Not yet recruiting Gemcitabine Hydrochloride Alone or With VX-970 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Conditions: Ovarian Serous Tumor;   Recurrent Fallopian Tube Carcinoma;   Recurrent Ovarian Carcinoma;   Recurrent Primary Peritoneal Carcinoma
Interventions: Drug: ATR Kinase Inhibitor VX-970;   Drug: Gemcitabine Hydrochloride;   Other: Laboratory Biomarker Analysis
14 Recruiting Total/Subtotal Colectomy in Ovarian Cancer
Conditions: Epithelial Ovarian Cancer;   Fallopian Tube Cancer;   Primary Peritoneal Carcinoma;   Secondary Malignant Neoplasm of Large Intestine
Interventions: Procedure: Total or Subtotal Colectomy;   Procedure: Other Bowel Resection
15 Recruiting Writing About Experiences With Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Behavioral: Writing about ovarian cancer
16 Not yet recruiting A Study of ABT-263 as Single Agent in Women With Platinum Resistant/Refractory Recurrent Ovarian Cancer
Condition: Platinum-resistant or Refractory Ovarian Cancer
Intervention: Drug: ABT-263
17 Not yet recruiting A Phase 1/2a Evaluation of the Safety and Efficacy of Adding AL3818 to Standard Platinum-Based Chemotherapy
Conditions: Endometrial Carcinoma;   Ovarian Carcinoma;   Fallopian Tube Carcinoma;   Primary Peritoneal Carcinoma;   Cervical Carcinoma
Interventions: Drug: AL3818;   Drug: Carboplatin;   Drug: Paclitaxel
18 Recruiting REGorafenib vsTamoxifen in Patients With Platinum-sensitive OVARian Carcinoma and Isolated Biological Progression
Condition: Ovarian Carcinoma
Interventions: Drug: Tamoxifen;   Drug: Regorafenib
19 Not yet recruiting MRI-Guided Stereotactic Body Radiation Therapy (SBRT) for Ovarian Cancer
Conditions: Cancer of Ovary;   Cancer of the Ovary;   Neoplasms, Ovarian;   Ovarian Cancer;   Ovary Cancer;   Ovary Neoplasms
Interventions: Device: MRI-guided SBRT;   Behavioral: EORTC QLQ-C30 Questionnaire;   Behavioral: EORTC QLQ-OV28 Questionnaire
20 Recruiting Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-meso
Conditions: Malignant Mesothelioma;   Pancreatic Cancer;   Ovarian Tumor;   Triple Negative Breast Cancer;   Endometrial Cancer;   Other Mesothelin Positive Tumors
Intervention: Biological: anti-meso-CAR vector transduced T cells

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years